Report Detail
Global Erythropoietin (EPO) Market Professional Survey Report 2019
- RnM3773541 |
- 23 September, 2019 |
- Global |
- 108 Pages |
- QYResearch |
- Pharma & Healthcare
Rising incidence of chronic diseases such as CKD and cancer resulting in anemia is a major growth driver of Erythropoietin (EPO) Drugs market.
According to the statistics published by the National Heart, Lung, and Blood Institute of the U.S. Department of Health & Human Services, over 3 million people are affected by anemia every year and this number is expected to increase over the forecast period. This showcases the need for erythropoietin-stimulating agents in the coming years.
The global Erythropoietin (EPO) market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Erythropoietin (EPO) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Erythropoietin (EPO) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Erythropoietin (EPO) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Erythropoietin (EPO) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Epoetin-alfa
Darbepoetin-alfa
Epoetin-beta
Others
Segment by Application
Anemia
Kidney Disorders
Other
Table of Contents
Executive Summary
1 Industry Overview of Erythropoietin (EPO)
- 1.1 Definition of Erythropoietin (EPO)
- 1.2 Erythropoietin (EPO) Segment by Type
- 1.2.1 Global Erythropoietin (EPO) Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Epoetin-alfa
- 1.2.3 Darbepoetin-alfa
- 1.2.4 Epoetin-beta
- 1.2.5 Others
- 1.3 Erythropoietin (EPO) Segment by Applications
- 1.3.1 Global Erythropoietin (EPO) Consumption Comparison by Applications (2014-2025)
- 1.3.2 Anemia
- 1.3.3 Kidney Disorders
- 1.3.4 Other
- 1.4 Global Erythropoietin (EPO) Overall Market
- 1.4.1 Global Erythropoietin (EPO) Revenue (2014-2025)
- 1.4.2 Global Erythropoietin (EPO) Production (2014-2025)
- 1.4.3 North America Erythropoietin (EPO) Status and Prospect (2014-2025)
- 1.4.4 Europe Erythropoietin (EPO) Status and Prospect (2014-2025)
- 1.4.5 China Erythropoietin (EPO) Status and Prospect (2014-2025)
- 1.4.6 Japan Erythropoietin (EPO) Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Erythropoietin (EPO) Status and Prospect (2014-2025)
- 1.4.8 India Erythropoietin (EPO) Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Erythropoietin (EPO)
- 2.3 Manufacturing Process Analysis of Erythropoietin (EPO)
- 2.4 Industry Chain Structure of Erythropoietin (EPO)
3 Development and Manufacturing Plants Analysis of Erythropoietin (EPO)
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Erythropoietin (EPO) Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Erythropoietin (EPO)
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Erythropoietin (EPO) Production and Capacity Analysis
- 4.2 Erythropoietin (EPO) Revenue Analysis
- 4.3 Erythropoietin (EPO) Price Analysis
- 4.4 Market Concentration Degree
5 Erythropoietin (EPO) Regional Market Analysis
- 5.1 Erythropoietin (EPO) Production by Regions
- 5.1.1 Global Erythropoietin (EPO) Production by Regions
- 5.1.2 Global Erythropoietin (EPO) Revenue by Regions
- 5.2 Erythropoietin (EPO) Consumption by Regions
- 5.3 North America Erythropoietin (EPO) Market Analysis
- 5.3.1 North America Erythropoietin (EPO) Production
- 5.3.2 North America Erythropoietin (EPO) Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Erythropoietin (EPO) Import and Export
- 5.4 Europe Erythropoietin (EPO) Market Analysis
- 5.4.1 Europe Erythropoietin (EPO) Production
- 5.4.2 Europe Erythropoietin (EPO) Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Erythropoietin (EPO) Import and Export
- 5.5 China Erythropoietin (EPO) Market Analysis
- 5.5.1 China Erythropoietin (EPO) Production
- 5.5.2 China Erythropoietin (EPO) Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Erythropoietin (EPO) Import and Export
- 5.6 Japan Erythropoietin (EPO) Market Analysis
- 5.6.1 Japan Erythropoietin (EPO) Production
- 5.6.2 Japan Erythropoietin (EPO) Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Erythropoietin (EPO) Import and Export
- 5.7 Southeast Asia Erythropoietin (EPO) Market Analysis
- 5.7.1 Southeast Asia Erythropoietin (EPO) Production
- 5.7.2 Southeast Asia Erythropoietin (EPO) Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Erythropoietin (EPO) Import and Export
- 5.8 India Erythropoietin (EPO) Market Analysis
- 5.8.1 India Erythropoietin (EPO) Production
- 5.8.2 India Erythropoietin (EPO) Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Erythropoietin (EPO) Import and Export
6 Erythropoietin (EPO) Segment Market Analysis (by Type)
- 6.1 Global Erythropoietin (EPO) Production by Type
- 6.2 Global Erythropoietin (EPO) Revenue by Type
- 6.3 Erythropoietin (EPO) Price by Type
7 Erythropoietin (EPO) Segment Market Analysis (by Application)
- 7.1 Global Erythropoietin (EPO) Consumption by Application
- 7.2 Global Erythropoietin (EPO) Consumption Market Share by Application (2014-2019)
8 Erythropoietin (EPO) Major Manufacturers Analysis
- 8.1 Amgen
- 8.1.1 Amgen Erythropoietin (EPO) Production Sites and Area Served
- 8.1.2 Amgen Product Introduction, Application and Specification
- 8.1.3 Amgen Erythropoietin (EPO) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Johnson & Johnson
- 8.2.1 Johnson & Johnson Erythropoietin (EPO) Production Sites and Area Served
- 8.2.2 Johnson & Johnson Product Introduction, Application and Specification
- 8.2.3 Johnson & Johnson Erythropoietin (EPO) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Roche
- 8.3.1 Roche Erythropoietin (EPO) Production Sites and Area Served
- 8.3.2 Roche Product Introduction, Application and Specification
- 8.3.3 Roche Erythropoietin (EPO) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Galenica
- 8.4.1 Galenica Erythropoietin (EPO) Production Sites and Area Served
- 8.4.2 Galenica Product Introduction, Application and Specification
- 8.4.3 Galenica Erythropoietin (EPO) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Emcure
- 8.5.1 Emcure Erythropoietin (EPO) Production Sites and Area Served
- 8.5.2 Emcure Product Introduction, Application and Specification
- 8.5.3 Emcure Erythropoietin (EPO) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Kyowa Hakko Kirin
- 8.6.1 Kyowa Hakko Kirin Erythropoietin (EPO) Production Sites and Area Served
- 8.6.2 Kyowa Hakko Kirin Product Introduction, Application and Specification
- 8.6.3 Kyowa Hakko Kirin Erythropoietin (EPO) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 3SBio
- 8.7.1 3SBio Erythropoietin (EPO) Production Sites and Area Served
- 8.7.2 3SBio Product Introduction, Application and Specification
- 8.7.3 3SBio Erythropoietin (EPO) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Biocon
- 8.8.1 Biocon Erythropoietin (EPO) Production Sites and Area Served
- 8.8.2 Biocon Product Introduction, Application and Specification
- 8.8.3 Biocon Erythropoietin (EPO) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 LG Life Sciences
- 8.9.1 LG Life Sciences Erythropoietin (EPO) Production Sites and Area Served
- 8.9.2 LG Life Sciences Product Introduction, Application and Specification
- 8.9.3 LG Life Sciences Erythropoietin (EPO) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
9 Development Trend of Analysis of Erythropoietin (EPO) Market
- 9.1 Global Erythropoietin (EPO) Market Trend Analysis
- 9.1.1 Global Erythropoietin (EPO) Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Erythropoietin (EPO) Regional Market Trend
- 9.2.1 North America Erythropoietin (EPO) Forecast 2019-2025
- 9.2.2 Europe Erythropoietin (EPO) Forecast 2019-2025
- 9.2.3 China Erythropoietin (EPO) Forecast 2019-2025
- 9.2.4 Japan Erythropoietin (EPO) Forecast 2019-2025
- 9.2.5 Southeast Asia Erythropoietin (EPO) Forecast 2019-2025
- 9.2.6 India Erythropoietin (EPO) Forecast 2019-2025
- 9.3 Erythropoietin (EPO) Market Trend (Product Type)
- 9.4 Erythropoietin (EPO) Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Erythropoietin (EPO) Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Erythropoietin (EPO). Industry analysis & Market Report on Erythropoietin (EPO) is a syndicated market report, published as Global Erythropoietin (EPO) Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Erythropoietin (EPO) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
